146 related articles for article (PubMed ID: 29246572)
1. Generation of two H1 hESC sublines carrying a heterozygous and homozygous knock-out of RB1.
Steenpass L
Stem Cell Res; 2017 Dec; 25():270-273. PubMed ID: 29246572
[TBL] [Abstract][Full Text] [Related]
2. Generation of heterozygous and homozygous hESC H9 sublines carrying inactivating mutations in RB1.
Schipper L; Kanber D; Steenpass L
Stem Cell Res; 2018 Dec; 33():41-45. PubMed ID: 30312872
[TBL] [Abstract][Full Text] [Related]
3. Generation of two H1 hESC sublines carrying deletions of RB1 exon 1/promoter in heterozygous or compound heterozygous state.
Menges J; Cremanns M; Steenpass L
Stem Cell Res; 2019 Aug; 39():101517. PubMed ID: 31404748
[TBL] [Abstract][Full Text] [Related]
4. Generation of human embryonic stem cell line with heterozygous RB1 deletion by CRIPSR/Cas9 nickase.
Tu J; Huo Z; Liu M; Wang D; Xu A; Zhou R; Zhu D; Gingold J; Shen J; Zhao R; Lee DF
Stem Cell Res; 2018 Apr; 28():29-32. PubMed ID: 29414415
[TBL] [Abstract][Full Text] [Related]
5. Biallelic and monoallelic deletion of the RB1 promoter in six isogenic clonal H9 hESC lines.
Döpper H; Horstmann M; Menges J; Bozet M; Kanber D; Steenpass L
Stem Cell Res; 2020 May; 45():101779. PubMed ID: 32268247
[TBL] [Abstract][Full Text] [Related]
6. Modeling Developmental and Tumorigenic Aspects of Trilateral Retinoblastoma via Human Embryonic Stem Cells.
Avior Y; Lezmi E; Yanuka D; Benvenisty N
Stem Cell Reports; 2017 May; 8(5):1354-1365. PubMed ID: 28392220
[TBL] [Abstract][Full Text] [Related]
7. Role of RB1 in human embryonic stem cell-derived retinal organoids.
Zheng C; Schneider JW; Hsieh J
Dev Biol; 2020 Jun; 462(2):197-207. PubMed ID: 32197890
[TBL] [Abstract][Full Text] [Related]
8. The survival gene MED4 explains low penetrance retinoblastoma in patients with large RB1 deletion.
Dehainault C; Garancher A; Castéra L; Cassoux N; Aerts I; Doz F; Desjardins L; Lumbroso L; Montes de Oca R; Almouzni G; Stoppa-Lyonnet D; Pouponnot C; Gauthier-Villars M; Houdayer C
Hum Mol Genet; 2014 Oct; 23(19):5243-50. PubMed ID: 24858910
[TBL] [Abstract][Full Text] [Related]
9. RB1 gene inactivation by chromothripsis in human retinoblastoma.
McEvoy J; Nagahawatte P; Finkelstein D; Richards-Yutz J; Valentine M; Ma J; Mullighan C; Song G; Chen X; Wilson M; Brennan R; Pounds S; Becksfort J; Huether R; Lu C; Fulton RS; Fulton LL; Hong X; Dooling DJ; Ochoa K; Mardis ER; Wilson RK; Easton J; Zhang J; Downing JR; Ganguly A; Dyer MA
Oncotarget; 2014 Jan; 5(2):438-50. PubMed ID: 24509483
[TBL] [Abstract][Full Text] [Related]
10. CRISPR/Cas9 mediated knockout of rb1 and rbl1 leads to rapid and penetrant retinoblastoma development in Xenopus tropicalis.
Naert T; Colpaert R; Van Nieuwenhuysen T; Dimitrakopoulou D; Leoen J; Haustraete J; Boel A; Steyaert W; Lepez T; Deforce D; Willaert A; Creytens D; Vleminckx K
Sci Rep; 2016 Oct; 6():35264. PubMed ID: 27739525
[TBL] [Abstract][Full Text] [Related]
11. Retinoblastoma.
Lohmann D
Adv Exp Med Biol; 2010; 685():220-7. PubMed ID: 20687510
[TBL] [Abstract][Full Text] [Related]
12. Heterozygous RB1 mutation enhanced ATP production in human iPSC-derived retinal organoids.
Vincent A; Krishnakumar S; Parameswaran S
Mol Biol Rep; 2024 May; 51(1):606. PubMed ID: 38704498
[TBL] [Abstract][Full Text] [Related]
13. RB1 gene mutations in Argentine retinoblastoma patients. Implications for genetic counseling.
Parma D; Ferrer M; Luce L; Giliberto F; Szijan I
PLoS One; 2017; 12(12):e0189736. PubMed ID: 29261756
[TBL] [Abstract][Full Text] [Related]
14. Generation of a Nrf2 homozygous knockout human embryonic stem cell line using CRISPR/Cas9.
Kim SJ; Habib O; Kim JS; Han HW; Koo SK; Kim JH
Stem Cell Res; 2017 Mar; 19():46-48. PubMed ID: 28413005
[TBL] [Abstract][Full Text] [Related]
15. Generation of induced pluripotent stem cells (iPSCs) from a retinoblastoma patient carrying a c.2663G>A mutation in RB1 gene.
Zeng S; Liu L; Ouyang Q; Zhao Y; Lin G; Hu L; Li W
Stem Cell Res; 2016 Sep; 17(2):208-211. PubMed ID: 27879208
[TBL] [Abstract][Full Text] [Related]
16. Generation of a human induced pluripotent stem cell line (VRFi001-A) from orbital adipose tissue of a bilateral retinoblastoma patient with heterozygous RB1 gene deletion.
Vincent A; Khetan V; Rishi P; Suganeswari G; Krishnakumar S; Krishnan UM; Parameswaran S
Stem Cell Res; 2018 May; 29():42-45. PubMed ID: 29579639
[TBL] [Abstract][Full Text] [Related]
17. A Parent-of-Origin Effect Impacts the Phenotype in Low Penetrance Retinoblastoma Families Segregating the c.1981C>T/p.Arg661Trp Mutation of RB1.
Eloy P; Dehainault C; Sefta M; Aerts I; Doz F; Cassoux N; Lumbroso le Rouic L; Stoppa-Lyonnet D; Radvanyi F; Millot GA; Gauthier-Villars M; Houdayer C
PLoS Genet; 2016 Feb; 12(2):e1005888. PubMed ID: 26925970
[TBL] [Abstract][Full Text] [Related]
18. Using RB1 mutations to assess minimal residual disease in metastatic retinoblastoma.
Dimaras H; Rushlow D; Halliday W; Doyle JJ; Babyn P; Abella EM; Williams J; Héon E; Gallie BL; Chan HS
Transl Res; 2010 Aug; 156(2):91-7. PubMed ID: 20627193
[TBL] [Abstract][Full Text] [Related]
19. Loss of RB1 induces non-proliferative retinoma: increasing genomic instability correlates with progression to retinoblastoma.
Dimaras H; Khetan V; Halliday W; Orlic M; Prigoda NL; Piovesan B; Marrano P; Corson TW; Eagle RC; Squire JA; Gallie BL
Hum Mol Genet; 2008 May; 17(10):1363-72. PubMed ID: 18211953
[TBL] [Abstract][Full Text] [Related]
20. RB1 mutation spectrum in a comprehensive nationwide cohort of retinoblastoma patients.
Dommering CJ; Mol BM; Moll AC; Burton M; Cloos J; Dorsman JC; Meijers-Heijboer H; van der Hout AH
J Med Genet; 2014 Jun; 51(6):366-74. PubMed ID: 24688104
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
